Europe Today
French biotech stock soars 40% after new data on experimental medicine
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.
This story was reported by Europe News. EUROPES curates Europe's most relevant coverage — read the full report at the original source.
Read full coverage at Europe News →